HIGH

LeMaitre Vascular Recalls Artegraft Collagen Vascular Graft Due to Labeling Issues

LeMaitre Vascular recalled 10 Artegraft Collagen Vascular Grafts on August 25, 2025, due to incorrect labeling. The devices lack CE and UKCA marks and are missing essential patient information. No distribution occurred within the U.S., but the affected products were sent to Great Britain and Switzerland.

Quick Facts at a Glance

Recall Date
August 25, 2025
Hazard Level
HIGH
Brand
LeMaitre Vascular
Category
Health & Personal Care
Sold At
Unknown
At-Risk Groups
GENERAL

Hazard Information

Devices were distributed with incorrect label without CE and UKCA mark, missing patient leaflet and patient implant card.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact LeMaitre Vascular, Inc. or your healthcare provider for instructions. Notification method: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Product Details

The recalled models are AG630M, AG636M, AG730M, AG740M, and AG845M. These devices were distributed internationally, with no sales in the U.S. The expiration date for the grafts is July 28, 2027.

The Hazard

The Artegraft devices were labeled incorrectly, lacking the required CE and UKCA marks. Missing patient leaflets and implant cards can lead to improper use and potentially serious health risks.

Reported Incidents

There are no reported incidents or injuries associated with the recalled grafts. The recall is a proactive measure to ensure patient safety.

What to Do

Patients and healthcare providers should cease use of the recalled grafts immediately. Contact LeMaitre Vascular, Inc. or your healthcare provider for further instructions.

Contact Information

For more information, contact LeMaitre Vascular at the telephone number provided in the recall notification. Additional details can be found at the FDA recall website.

Key Facts

  • Recall date: August 25, 2025
  • Quantity recalled: 10 units
  • Distribution: International only
  • No injuries reported
  • High hazard level

Get Alerts for Health & Personal Care Recalls

Get notified about recalls in categories you care about.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
AG630M
AG636M
AG730M
AG740M
AG845M
Report Date
October 15, 2025
Source Agency
FDA - Medical Devices
Recall Status
ACTIVE

Related Recalls

HIGH

Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 60687-695-01 - Carton NDC [60687-695-11- Unit Dose]

CGMP Deviations: The recalling firm filed for Chapter 11 on September 30, 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.

SUCRALFATE
CGMP Deviations:
Read more